4CBY

Design, synthesis, and biological evaluation of potent and selective Class IIa HDAC inhibitors as a potential therapy for Huntington's disease

Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.

Version Number	Version Date	Version Type/Reason	Version Change	Revised CIF Category
1.0	2013-12-11	Initial release
1.1	2014-01-15		Database references
1.2	2018-02-07		Database references, Structure summary	audit_author, citation, citation_author, struct
1.3	2024-05-08		Data collection, Database references, Derived calculations, Other	chem_comp_atom, chem_comp_bond, database_2, pdbx_database_status, pdbx_struct_conn_angle, struct_conn, struct_site	Download

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.